Medtronic plc (MDT) – Higher costs affecting company performance

This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for insights on any specific sector/industry and market recommendations

Medtronic plc (MDT) Q3FY23

Medtronic plc is holds a strong space in the medical device industry. The company’s broad product based and strong pipeline makes it a leader among the players like Stryker Corporation and Boston
Scientific Corporation

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance of Medtronic

Crispidea Coverage

No of Pages: 34

To view the previous quarter’s report click here

Follow our LinkedIn page for more updates